| Trial ID: | L0143 |
| Source ID: | NCT04977661
|
| Associated Drug: |
Vitamin E
|
| Title: |
Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis (NASH)
|
| Interventions: |
Drug: Vitamin E|Drug: Ursodeoxycholic acid|Drug: Pentoxifylline
|
| Outcome Measures: |
Resolution of NASH|Normalization of hepatic aminotransferases(ALT and AST)
|
| Sponsor/Collaborators: |
Kafrelsheikh University
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
102
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment
|
| Start Date: |
February 1, 2020
|
| Completion Date: |
January 10, 2021
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 27, 2021
|
| Locations: |
Hepatology, gastroenterology and infectious diseases department at Kafrelsheikh University Hospital, Cairo, Egypt
|
| URL: |
https://ClinicalTrials.gov/show/NCT04977661
|
